Loading...
Quanterix Corporation
QTRX•NASDAQ
Healthcare
Medical - Devices
$5.85
$0.34(6.17%)
Quanterix Corporation (QTRX) Financial Performance & Income Statement Overview
Review Quanterix Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.68%
↑ 10.68%
Operating Income Growth
-18.37%
↓ 18.37%
Net Income Growth
-19.17%
↓ 19.17%
Operating Cash Flow Growth
-86.03%
↓ 86.03%
Operating Margin
-48.78%
↓ 48.78%
Gross Margin
57.95%
↑ 57.95%
Net Profit Margin
-36.93%
↓ 36.93%
ROE
-15.12%
↓ 15.12%
ROIC
-18.53%
↓ 18.53%
Quanterix Corporation (QTRX) Income Statement & Financial Overview
Review Quanterix Corporation's (QTRX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $35.16M | $35.41M | $34.38M | $32.07M |
| Cost of Revenue | $12.99M | $15.66M | $14.32M | $12.44M |
| Gross Profit | $22.17M | $19.75M | $20.06M | $19.63M |
| Gross Profit Ratio | $0.63 | $0.56 | $0.58 | $0.61 |
| R&D Expenses | $8.07M | $8.10M | $8.10M | $6.67M |
| SG&A Expenses | $28.87M | $23.80M | $25.06M | $26.92M |
| Operating Expenses | $35.88M | $31.50M | $32.91M | $33.59M |
| Total Costs & Expenses | $46.34M | $47.16M | $47.49M | $46.03M |
| Interest Income | $3.49M | $3.54M | $3.68M | $3.95M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $3.62M | $776000.00 | $2.44M | $2.001M |
| EBITDA | -$11.15M | -$10.97M | -$10.67M | -$12.44M |
| EBITDA Ratio | -$0.32 | -$0.31 | -$0.31 | -$0.39 |
| Operating Income | -$14.77M | -$11.75M | -$13.11M | -$13.97M |
| Operating Income Ratio | -$0.42 | -$0.33 | -$0.38 | -$0.44 |
| Other Income/Expenses (Net) | $3.13M | $3.54M | $3.67M | $4.15M |
| Income Before Tax | -$11.64M | -$8.21M | -$9.44M | -$9.81M |
| Income Before Tax Ratio | -$0.33 | -$0.23 | -$0.27 | -$0.31 |
| Income Tax Expense | -$8000.00 | $145000.00 | $37000.00 | $260000.00 |
| Net Income | -$11.63M | -$8.35M | -$9.47M | -$10.07M |
| Net Income Ratio | -$0.33 | -$0.24 | -$0.28 | -$0.31 |
| EPS | -$0.30 | -$0.22 | -$0.25 | -$0.26 |
| Diluted EPS | -$0.30 | -$0.22 | -$0.25 | -$0.26 |
| Weighted Avg Shares Outstanding | $38.55M | $38.45M | $38.34M | $38.13M |
| Weighted Avg Shares Outstanding (Diluted) | $38.55M | $38.45M | $38.34M | $38.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan